Skip to main content
Clinical Trials/NCT06049992
NCT06049992RecruitingNot Applicable

Stylet-driven vs. Lumenless Lead in Left-Bundle-Branch Pacing Randomized Trial

Puerta de Hierro University Hospital4 sites in 1 country120 target enrollmentStarted: September 21, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
120
Locations
4
Primary Endpoint
Proportion of patients in which left-bundle branch pacing is achieved at implantation

Study Overview

Brief Summary

The STYLE-LBBP study aims to compare the efficacy and safety of left-bundle branch pacing between the two types of available pacing leads: lumenless vs stylet-driven.

Detailed Description

STYLE-LBBP is a randomized, non-blinded, multicenter clinical trial that compares the efficacy and safety of two types of available pacing leads in conduction system pacing (CSP). Patients referred to CSP who meet the inclusion and exclusion criteria will be enrolled and randomized into two groups: i)Left bundle branch pacing (LBBP) using leads without internal light (Lumenless; Medtronic Selectsecure 3830, Minneapolis, USA) or ii) LBBP with stylet-driven leads (Tendril STS 2088TC, Abbott, Inc., USA; Solia S60, Biotronik, SE & Co., KG, Germany; Ingevity +, Boston Scientific, Marlborough, MA, USA).

Efficacy in terms of achieving LBBP (selective and non-selective left bundle capture criteria) will be measured at implantation and after 24 hours. Complications of the procedure will also be recorded.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years
  • Patients referred for conduction system pacing

Exclusion Criteria

  • Patients with a prosthetic (metal or biologic) tricuspid valve.

Outcomes

Primary Outcomes

Proportion of patients in which left-bundle branch pacing is achieved at implantation

Time Frame: Baseline (During implantation)

Defined as a paced (pseudo) right bundle branch block QRS morphology with terminal r/R' in lead V1 and any of the following: i) recording of a LBB potential during intrinsic rhythm (only in patients with normal ventricular activation), ii) transition from non-selective to selective LBBP or non-selective LBBP to LV myocardial capture during decreasing pacing output, iii) abrupt shortening of stimulus to R wave peak time in V6 ECG lead (V6RWPT) ≥10 ms during implantation, iv) V6RWPT \< 75ms or \< 80ms in patients with preexisting left bundle branch block or v) an interpeak interval (V1RWPT - V6RWPT) ≥ 33ms.

Proportion of patients with left-bundle branch pacing criteria at 24 hours

Time Frame: At 24 hours (before discharge)

Defined as a paced (pseudo) right bundle branch block QRS morphology with terminal r/R' in lead V1 and any of the following: i) recording of a LBB potential during intrinsic rhythm (only in patients with normal ventricular activation), ii) transition from non-selective to selective LBBP or non-selective LBBP to LV myocardial capture during decreasing pacing output, iii) abrupt shortening of stimulus to R wave peak time in V6 ECG lead (V6RWPT) ≥10 ms during implantation, iv) V6RWPT \< 75ms or \< 80ms in patients with preexisting left bundle branch block or v) an interpeak interval (V1RWPT - V6RWPT) ≥ 33ms.

Secondary Outcomes

  • Procedural complications(At 24 hours)

Investigators

Sponsor
Puerta de Hierro University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alvaro Lorente-Ros

Principal investigator

Puerta de Hierro University Hospital

Study Sites (4)

Loading locations...

Similar Trials